SavedAdd your journal

Journals / Türkiye Acil Tıp Dergisi / 2009 / Cilt: 9 - Sayı: 2

Kalp yetmezliği hastalarında "bi-level positive airway pressure" uygulamasının sonuçları: Düşünüldüğünden daha mı güvenli?

Outcomes in patients with congestive heart failure treated with bi-level positive airway pressure: Safer than previously thought?

Tricia ROTTER
Robert J. TUBBS
Jonathan VALENTE
Robert PARTRIDGE
Pages
53–58
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patents receiving medical therapy alone had an AMIrate of 6.2%, compared with 15.8% of patents on BiPAP, and 32.4% of intubated patents (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectve: Previous studies indicate that bi-level positve airway pressure (BiPAP) for congestve heart failure (CHF)may increase the rate of myocardial infarcton (AMI).
📊
Key Findings & Data:We compare rates of AMI and death in patents receivingmedical therapy, BiPAP or intubaton for CHF in the emergency department (ED).Methods: Retrospectve chart review of ED patents with CHF over 2 years.
💡
Conclusion & Impact:Patents receiving medical therapy alone had an AMIrate of 6.2%, compared with 15.8% of patents on BiPAP, and 32.4% of intubated patents (p
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectve: Previous studies indicate that bi-level positve airway pressure (BiPAP) for congestve heart failure (CHF)may increase the rate of myocardial infarcton (AMI). We compare rates of AMI and death in patents receivingmedical therapy, BiPAP or intubaton for CHF in the emergency department (ED).Methods: Retrospectve chart review of ED patents with CHF over 2 years. Results: 745 subjects were enrolled. 553 (74.2%) received medical therapy alone; 158 (21.2%) received BiPAP andmedical therapy; 34 patents (4.6%) were intubated in the ED. Patents receiving medical therapy alone had an AMIrate of 6.2%, compared with 15.8% of patents on BiPAP, and 32.4% of intubated patents (p

Özet

Amaç: Daha önceki çalışmalar konjestf kalp yetmezliğinde ‘bi-level positve airway pressure’ (BİPAP) kullanımı- nın miyokard infarktüsü (MI) oranını artrdığını belirtmişlerdir. Biz bu çalışmada, acil serviste kalp yetmezliği ne- deniyle medikal tedavi, BİBAP veya entübe edilerek tedavi edilen hastalarda MI ve ölüm oranlarını karşılaştrma- yı amaçladık.Gereç ve Yöntem: Acil servise son iki yılda kalp yetmezliği nedeniyle başvuran hastaların dosyaları geriye dönük ola- rak incelendi.Bulgular: Çalışmaya 745 hasta dahil edildi. Çalışma hastalarının 553’ü (%74.2) sadece medikal tedavi, 158’i (%21.2)BİPAP ve medikal tedavi ,34 (%4.6) hasta ise entübe edilerek tedavi edildi. Sadece medikal tedavi alan hastaların%6.2’si, BİPAP uygulananların %15.8’i ve entübe edilenlerin de %32.4’ünde MI gelişt (p

🔖

Cite This Article

ROTTER, T., TUBBS, R. J., VALENTE, J., PARTRIDGE, R. (2022). Kalp yetmezliği hastalarında "bi-level positive airway pressure" uygulamasının sonuçları: Düşünüldüğünden daha mı güvenli?. Türkiye Acil Tıp Dergisi, Cilt: 9 - Sayı: 2, 53–58. https://ajindex.com/articles/626103

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Summers RL, Patch J, Kolb JC. Effect of the initiation of noninvasive bilevel positive airway pressure on haemodynamic stability. Eur J Emerg Med 2002;9:37-41
  2. Yosefy C, Hay E, Ben-Barak A, Derazon H, Magen E, Reisin L, et al. BiPAP ventilation as assistance for patients presenting with respiratory distress in the department of emergency medicine. Am J Respir Med 2003;2:343-7
  3. Mehta S, Jay GD, Woolard RH, Hipona RA, Connolly EM, Cimini DM, et al. Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. Crit Care Med 1997;25:620-8
  4. Levitt MA. A prospective, randomized trial of BiPAP in severe acute congestive heart failure. J Emerg Med 2001;21:363-9
  5. Sharon A, Shpirer I, Kaluski E, Moshkovitz Y, Milovanov O, Polak R, et al. High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. J Am Coll Cardiol 2000;36:832-7
  6. WHO MONICA Project. MONICA Manual, rev ed. Geneva: Cardiovascular Diseases Unit, WHO; 1990
  7. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefned-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefnition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69
  8. Pingleton SK. Complications of acute respiratory failure. Am Rev Respir Dis 1998;137:1463-93
  9. Schwartz DE, Matthay MA, Cohen NH. Death and other complications of emergency airway management in critically ill adults. A prospective investigation of 297 tracheal intubations. Anesthesiology 1995;82:367-76
  10. Mort TC. Emergency tracheal intubation: complications associated with repeated laryngoscopic attempts. Anesth Analg 2004;99:607-13
  11. Bersten AD, Holt AW, Vedig AE, Skowronski GA, Baggoley CJ. Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. N Engl J Med 1991;325:1825-30
  12. Lin M, Chiang HT. The effcacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. J Formos Med Assoc 1991;90:736-43
  13. Lin M, Yang YF, Chiang HT, Chang MS, Chiang BN, Cheitlin MD. Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Short-term results and long-term follow-up. Chest 1995;107:1379-86
  14. Velez LI, Benitez FL, Nazeer SR. Noninvasive ventilation in the emer- gency department. Emerg